Tredje AP fonden Cuts Stock Holdings in DaVita Inc. (NYSE:DVA)

Tredje AP fonden decreased its holdings in shares of DaVita Inc. (NYSE:DVA) by 50.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,424 shares of the company’s stock after selling 4,424 shares during the quarter. Tredje AP fonden’s holdings in DaVita were worth $662,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of DVA. SBI Securities Co. Ltd. purchased a new position in shares of DaVita during the fourth quarter worth about $41,000. Quarry LP purchased a new position in shares of DaVita during the third quarter worth about $60,000. Venturi Wealth Management LLC grew its holdings in shares of DaVita by 59.8% during the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock worth $61,000 after purchasing an additional 152 shares in the last quarter. Versant Capital Management Inc boosted its stake in DaVita by 58.7% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $68,000 after buying an additional 169 shares in the last quarter. Finally, Blue Trust Inc. boosted its stake in DaVita by 39.7% in the fourth quarter. Blue Trust Inc. now owns 461 shares of the company’s stock worth $76,000 after buying an additional 131 shares in the last quarter. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Price Performance

Shares of DaVita stock opened at $143.56 on Friday. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The company has a market cap of $11.48 billion, a PE ratio of 13.37, a P/E/G ratio of 1.07 and a beta of 0.99. The business has a 50 day moving average of $158.92 and a 200 day moving average of $157.62. DaVita Inc. has a 52 week low of $125.64 and a 52 week high of $179.60.

DaVita (NYSE:DVA) last announced its earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, equities research analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Sanford C. Bernstein set a $184.00 target price on DaVita in a research note on Friday, February 21st. Cowen reaffirmed a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. Finally, Barclays upped their target price on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 18th. One analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $166.33.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.